Literature DB >> 7096535

Qualitative receptor defects in families with androgen resistance: failure of stabilization of the fibroblast cytosol androgen receptor.

J E Griffin, J L Durrant.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7096535     DOI: 10.1210/jcem-55-3-465

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  13 in total

Review 1.  Molecular basis of androgen resistance.

Authors:  M Marcelli; W D Tilley; S Zoppi; J E Griffin; J D Wilson; M J McPhaul
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

2.  High efficiency covalent radiolabeling of the human androgen receptor. Studies in cultured fibroblasts using dihydrotestosterone 17 beta-bromoacetate.

Authors:  W J Kovacs; M K Turney
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 3.  Molecular genetics of human androgen insensitivity.

Authors:  T R Brown; P A Scherer; Y T Chang; C J Migeon; P Ghirri; K Murono; Z Zhou
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

4.  Expression of a mutant androgen receptor in cloned fibroblasts derived from a heterozygous carrier for the syndrome of testicular feminization.

Authors:  M K Elawady; D R Allman; J E Griffin; J D Wilson
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

5.  A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.

Authors:  W J Kovacs; J E Griffin; D D Weaver; B R Carlson; J D Wilson
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 6.  The androgen resistance syndromes: clinical and biochemical aspects.

Authors:  H U Schweikert
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

7.  Pituitary apoplexy developed in a patient with androgen insensitivity syndrome.

Authors:  H Watanobe; H Kawabe
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

8.  High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.

Authors:  P Price; J A Wass; J E Griffin; M Leshin; M O Savage; D M Large; D E Bu'Lock; D C Anderson; J D Wilson; G M Besser
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.

Authors:  M Marcelli; S Zoppi; C M Wilson; J E Griffin; M J McPhaul
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Reduced affinity of the androgen receptor for 5 alpha-dihydrotestosterone but not methyltrienolone in a form of partial androgen resistance. Studies on cultured genital skin fibroblasts.

Authors:  L Pinsky; M Kaufman; A E Chudley
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.